CygnusMed Clinches $150K Seed Round to Revolutionize Single-Arterial Endovascular Interventions

CygnusMed, Inc. is excited to announce a successful funding round in which the company raised $150,000 to support its groundbreaking innovations in medical technology.

This significant injection of capital will accelerate the further development and deployment of the Cygnus device—an advanced system that is setting new standards in endovascular interventions.

Unlike traditional methods that require dual arterial access, the Cygnus device allows clinicians to perform all neuro and peripheral endovascular procedures through a single artery access while simultaneously providing continuous arterial blood pressure measurement.

This innovative approach not only simplifies the procedure but also substantially decreases blood loss and enhances patient safety.

The newly raised funds will be strategically allocated to optimize product development, expand clinical research, and enhance patient outcomes by refining device functionalities.

With this financial backing, CygnusMed is positioned to advance its development pipeline, invest in critical regulatory pathways, and ultimately bring the life-saving benefits of the Cygnus device to a broader market sooner.

The investment also underscores the growing confidence in the potential of integrated medical technologies to transform standard practices in interventional procedures.

As the company continues to push the boundaries of conventional treatment methodologies, its focus remains firmly on addressing unmet clinical needs and improving efficiency in medical settings.

This funding round is more than just an economic milestone—it is a testament to the unwavering commitment of CygnusMed, Inc.

and its partners to revolutionize patient care through innovative, science-driven solutions.